Hemostatic and fibrinolytic effects of systemic prostaglandin E1 therapy in patients with peripheral arterial disease. [electronic resource]
Producer: 20040115Description: 145-8 p. digitalISSN:- 0301-1526
- Aged
- Aged, 80 and over
- Alprostadil -- administration & dosage
- Arterial Occlusive Diseases -- blood
- Blood Coagulation Factors -- metabolism
- Blood Coagulation Tests
- Female
- Fibrinolysis -- drug effects
- Fibrinolytic Agents -- adverse effects
- Hemorrhage -- blood
- Hemostasis -- drug effects
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Risk Assessment
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.